Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis
| Errataetall: |
CommentOn: Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101816. - PMID 34607067 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Clinics and research in hepatology and gastroenterology - 46(2022), 4 vom: 15. Apr., Seite 101842 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Athyros, Vasilios G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 02.06.2022 Date Revised 15.06.2022 published: Print-Electronic CommentOn: Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101816. - PMID 34607067 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clinre.2021.101842 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334562864 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334562864 | ||
| 003 | DE-627 | ||
| 005 | 20231225223954.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinre.2021.101842 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1115.xml |
| 035 | |a (DE-627)NLM334562864 | ||
| 035 | |a (NLM)34920141 | ||
| 035 | |a (PII)S2210-7401(21)00220-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Athyros, Vasilios G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.06.2022 | ||
| 500 | |a Date Revised 15.06.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101816. - PMID 34607067 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |2 NLM | |
| 700 | 1 | |a Katsiki, Niki |e verfasserin |4 aut | |
| 700 | 1 | |a Mikhailidis, Dimitri P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinics and research in hepatology and gastroenterology |d 2011 |g 46(2022), 4 vom: 15. Apr., Seite 101842 |w (DE-627)NLM201280868 |x 2210-741X |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2022 |g number:4 |g day:15 |g month:04 |g pages:101842 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clinre.2021.101842 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2022 |e 4 |b 15 |c 04 |h 101842 | ||